Advertisement
Advertisement
ATHE
Alterity Therapeutics Ltd - ADR
2.04
USD-0.23
-10.13%
Dec 18, 14:55 UTC -5
Closed
...
Alterity Therapeutics Ltd - ADR Profile
About
Info & Links
CEO
David A. Stamler
Headquarters
Melbourne, C3 VIC 3000, AUSTRALIA
Industry
Sector
Auditor
PricewaterhouseCoopers
Share holders
5,552
Employees
10
Alterity Therapeutics Ltd - ADR Statistics
Valuation Measures
Market Capitalization2
14.89M
Enterprise Value
6.60M
Enterprise Value/EBITDA(ttm)
--
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
1.94
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
0.00%
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
0.00
Net Income Available to Common(ttm)
0.00
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
0.95
52-Week Change
-51.43%
S&P 500 52-Week Change
23.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
8.74M
Dividend Yield
0.00%
Float4
4.47M
% Held by Insiders
38.80%
% Held by Institutions
2.14%
Balance Sheet
Total Cash(mrq)
8.29M
Total Cash Per Share(mrq)
0.95
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
--
Quick Ratio(mrq)
3.54%
Book Value Per Share(mrq)
--
Cash Flow
Operating Cash Flow Per Share(ytd)
--
Free Cash Flow(ytd)
0.00
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement